BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32207273)

  • 1. Protein Expression of Cyclin B1, Transferrin Receptor, and Fibronectin Is Correlated with the Prognosis of Adrenal Cortical Carcinoma.
    Moon SJ; Kim JH; Kong SH; Shin CS
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):132-141. PubMed ID: 32207273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.
    Tian X; Xu WH; Anwaier A; Wang HK; Wan FN; Cao DL; Luo WJ; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2021 Apr; 25(8):3898-3911. PubMed ID: 33626208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma.
    Chifu I; Heinze B; Fuss CT; Lang K; Kroiss M; Kircher S; Ronchi CL; Altieri B; Schirbel A; Fassnacht M; Hahner S
    Front Endocrinol (Lausanne); 2020; 11():597878. PubMed ID: 33281749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
    Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
    J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Protein Expression of both
    Brondani VB; Lacombe AMF; Mariani BMP; Montenegro L; Soares IC; Bezerra-Neto JE; Tanno FY; Srougi V; Chambo JL; Mendonca BB; Almeida MQ; Zerbini MCN; Fragoso MCBV
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma.
    Poli G; Ceni E; Armignacco R; Ercolino T; Canu L; Baroni G; Nesi G; Galli A; Mannelli M; Luconi M
    Oncotarget; 2015 Mar; 6(8):5695-706. PubMed ID: 25691058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
    Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
    Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
    Fenske W; Völker HU; Adam P; Hahner S; Johanssen S; Wortmann S; Schmidt M; Morcos M; Müller-Hermelink HK; Allolio B; Fassnacht M
    Endocr Relat Cancer; 2009 Sep; 16(3):919-28. PubMed ID: 19465749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
    Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
    Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study.
    Zhang F; Liu Z; Liang J; Liu S; Wu K; Zhang F; Zhou C; Lu Y; Zhu Y; Wang X
    BMC Cancer; 2021 Aug; 21(1):961. PubMed ID: 34445989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
    Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
    Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of GMNN predicts malignant progression and poor prognosis in ACC.
    Zhao X; Zhang X; Shao S; Yang Q; Shen C; Yang X; Jiao W; Liu J; Wang Y
    Eur J Med Res; 2022 Dec; 27(1):301. PubMed ID: 36539849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
    Aronova A; Min IM; Crowley MJP; Panjwani SJ; Finnerty BM; Scognamiglio T; Liu YF; Whitsett TG; Garg S; Demeure MJ; Elemento O; Zarnegar R; Fahey TJ
    Ann Surg Oncol; 2018 Mar; 25(3):792-800. PubMed ID: 29214451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging.
    Sun N; Kunzke T; Sbiera S; Kircher S; Feuchtinger A; Aichler M; Herterich S; Ronchi CL; Weigand I; Schlegel N; Waldmann J; Candida Villares Fragoso M; Whitsett TG; Gill AJ; Fassnacht M; Walch A; Kroiss M
    Clin Chem; 2019 Oct; 65(10):1276-1286. PubMed ID: 31492715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?
    Bulzico D; Faria PAS; Maia CB; de Paula MP; Torres DC; Ferreira GM; Pires BRB; Hassan R; Abdelhay E; Vaisman M; Vieira Neto L
    Endocrine; 2017 Nov; 58(2):276-288. PubMed ID: 28887601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of cyclin B1 in solid tumors: a meta-analysis.
    Ye C; Wang J; Wu P; Li X; Chai Y
    Oncotarget; 2017 Jan; 8(2):2224-2232. PubMed ID: 27903976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma.
    Babu KR; Muckenthaler MU
    Sci Rep; 2019 Feb; 9(1):1518. PubMed ID: 30728365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.
    Liang R; Weigand I; Lippert J; Kircher S; Altieri B; Steinhauer S; Hantel C; Rost S; Rosenwald A; Kroiss M; Fassnacht M; Sbiera S; Ronchi CL
    Front Endocrinol (Lausanne); 2020; 11():219. PubMed ID: 32373071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.